Improving Outcomes for Eosinophilic Esophagitis: Practice-Changing Tips for the Practicing Clinician Podcast 3: An evolving treatment landscape for eosinophilic esophagitis: An allergist’s perspective Pre-test

Start patient on budesonide oral suspension therapy

Start patient on fluticasone propionate orally disintegrating tablets

Consider esophageal dilation of residual esophageal stricture

Start patient on dupilumab, which targets the IL-4 receptor alpha chain and disrupts signaling through the Th2 cytokines, IL-4 and IL-13